English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Medicine BioTech
EC Healthcare and AXA Jointly Establish the FIRST AXA Medical Centre
Sep 08, 2022 17:20 HKT
Sirnaomics to Present at 3rd Annual Jefferies Asia Forum
Sep 06, 2022 18:51 HKT
Oculis announces publication of Phase 2 data showing topical OCS-01 improves macular thickness and visual acuity in patients with diabetic macular edema
Sep 06, 2022 18:22 HKT
Avance Clinical Announces North American CRO Acquisition to Expand Later Phase Services for Biotechs
Sep 06, 2022 13:00 HKT
Dammam Valley to acquire majority in Arcensus GmbH; accelerating Whole Genome Sequencing in genetic diagnostics, delivering breakthrough technologies in genomic bioinformatics
Sep 05, 2022 20:00 HKT
Novotech at ESMO Congress 2022 - New Data Shows 100% Oncology Trials Growth in APAC
Sep 05, 2022 18:00 HKT
EC Healthcare Chairman Mr. Eddy Tang Increases Shareholding, Demonstrating Full Confidence in the Group's Future Development
Sep 02, 2022 17:31 HKT
Legend Capital: The Logic of Technology Investment Has Changed
Sep 02, 2022 17:05 HKT
Younger Colorectal Cancer Population Highlights the Importance of Early Screening, Highly Sensitive Test Product Prenetics has Launched the Market
Sep 02, 2022 14:33 HKT
APAC Attracts 50% of Global Clinical Trials According to New GlobalData Report
Sep 02, 2022 14:00 HKT
CT Event Asia to host ASEAN Healthcare Transformation Summit 2022
Sep 01, 2022 15:50 HKT
Transcenta Holding (06628): Product pipeline progressing well with significant competitive differentiation
Sep 01, 2022 10:31 HKT
Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio
Aug 30, 2022 21:00 HKT
Malaysian Genomics Reports RM28.36 Million Full-Year Revenue
Aug 30, 2022 14:00 HKT
Strengthen technological innovation, Basecare Medical Announces 2022 Interim Results
Aug 29, 2022 18:30 HKT
Avance Clinical Sponsors Biotech Company of the Year Awards at Informa Pharma Intelligence Awards 2022
Aug 29, 2022 18:00 HKT
Malaysian Genomics Signs MoU with Ajlan to explore distribution of biopharmaceutical and genetic screening services in MENA region
Aug 29, 2022 14:00 HKT
Sirnaomics Achieves 100% Complete Response in Phase II Clinical Trial of STP705 for Treatment of Cutaneous Basal Cell Carcinoma
Aug 29, 2022 12:46 HKT
Sirnaomics Advances GalAhead(TM)-Based RNAi Therapeutics for Treatment of Complement-Related Diseases
Aug 26, 2022 20:15 HKT
Zhaoke Ophthalmology Announces 2022 Interim Results
Aug 24, 2022 20:37 HKT
<< Previous  Next >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: